• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION FREESTYLE AORTIC ROOT BIOPROSTHESIS; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 995
Device Problems Gradient Increase (1270); Obstruction of Flow (2423)
Patient Problems Pulmonary Regurgitation (2023); Pulmonary Valve Stenosis (2024)
Event Date 09/01/2006
Event Type  Injury  
Manufacturer Narrative
Citation: bilal ms et al.Intermediate-term results of medtronic freestyle valve for right ventricular outflow tract reconstruction in the ross procedure.J heart valve dis.2006 sep;15(5):696-701.Doi: not available.Earliest date of publish used for event date (month and year valid).No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the efficacy of alternative methods to the homograft valve for right ventricular outflow tract (rvot) reconstruction during the ross procedure.All data were collected from a single center between march 1997 and april 2005.The study population included 16 patients (predominantly male; mean age 18 years), 14 of which were implanted with medtronic freestyle bioprosthetic valves (no serial numbers provided).Among all patients, 2 deaths occurred due to: severe pneumonia at 6 months post implant and unknown causes at 3 years post implant.It was reported that the freestyle valves in both patients were ¿functioning normally at postoperative control echocardiography.¿ based on the available information, medtronic product was not directly associated with the deaths.Among all patients, adverse events included: valve explant and replacement due to pulmonary stenosis and increased peak gradient of 60 mmhg at 4 years post implant (one (b)(6)-year-old freestyle patient), elevated gradients, and mild regurgitation.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE AORTIC ROOT BIOPROSTHESIS
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8841946
MDR Text Key152669992
Report Number2025587-2019-02396
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
P970031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 07/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/30/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number995
Device Catalogue Number995
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/10/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age18 YR
-
-